Topic summary
Ad5-nCoV
Extracted from the Wikipedia article Convidecia.
AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccinefor COVID-19 that is also used as an inhaled booster. It was developed by CanSino Biologics, with Phase III trials conducted in Argentina, Chile, Mexico, Pakistan, Russia, and Saudi Arabia with 40,000 participants.